All data are based on the daily closing price as of July 18, 2024
g

GemVax&KAEL

082270.KQ
8.06 USD
-0.13
-1.59%

Overview

Last close
8.06 usd
Market cap
287.43M usd
52 week high
12.64 usd
52 week low
7.37 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
6.1983
Price/Book Value
4.1527
Enterprise Value
320.00M usd
EV/Revenue
6.1269
EV/EBITDA
-19.3245

Key financials

Revenue TTM
57.06M usd
Gross Profit TTM
13.50M usd
EBITDA TTM
1.66M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
101.78M usd
Net debt
N/A usd

About

GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.
  • Symbol
    082270.KQ
  • Exchange
    KQ
  • Isin
    KR7082270000
  • Country
    South Korea
  • Sector
    Technology
  • Industry
    Semiconductors & Semiconductor Equipment
  • CEO
    Mr. Sang-Jae Kim
  • Headquarter
    Daejeon
  • Web site
    https://www.gemvax.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top